Ratings Delfi Limited

Equities

P34

SG1Q25921608

Delayed Singapore S.E. Other stock markets 05:04:51 2024-04-30 am EDT			5-day change	1st Jan Change
0.91 ^SGD	+1.68%		+1.68%	-18.75%

Apr. 05	Delfi Limited Announces Board Changes	CI
Apr. 05	Delfi Limited Announces Retirement of Davinder Singh S/O Amar Singh as A Non-Executive Non-Independent Director	CI

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company has a low valuation given the cash flows generated by its activity.
The company is one of the best yield companies with high dividend expectations.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

The company's earnings growth outlook lacks momentum and is a weakness.
Revenue estimates are regularly revised downwards for the current and coming years.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Food Processing

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
DELFI LIMITED	-18.75%	408M		C+
LINDT	+4.31%	26.77B		B+
BARRY CALLEBAUT AG	+4.58%	8.86B		A-
TOOTSIE ROLL INDUSTRIES, INC.	-7.94%	2.16B	-	D
MORINAGA&CO., LTD.	-0.41%	1.47B		-
JOHN B. SANFILIPPO & SON, INC.	-3.24%	1.16B	-	C
GUAN CHONG	+49.73%	675M		B-
CLOETTA AB	-10.26%	427M		B+
JOSEF MANNER & COMP. AG	-0.90%	222M	-	-
WAWEL S.A.	-15.47%	202M		-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes